Healthcare provider profile · identity verified

Leslie M Pearson, MD

Family Practice · LAKEWOOD, CO · NPI 1447444807

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	314	99
Levothyroxine Sodium	Levothyroxine Sodium	236	74
Lisinopril	Lisinopril	222	78
Alendronate Sodium	Alendronate Sodium	190	77
Amlodipine Besylate	Amlodipine Besylate	155	55
Metformin Hcl	Metformin Hcl	136	42
Losartan Potassium	Losartan Potassium	129	48
Simvastatin	Simvastatin	123	36
Omeprazole	Omeprazole	121	56
Rosuvastatin Calcium	Rosuvastatin Calcium	110	37
Gabapentin	Gabapentin	109	60
Albuterol Sulfate Hfa	Albuterol Sulfate	91	50
Hydrochlorothiazide	Hydrochlorothiazide	86	29
Atenolol	Atenolol	73	23
Famotidine	Famotidine	73	27
Meloxicam	Meloxicam	73	41
Trazodone Hcl	Trazodone Hcl	73	29
Glipizide	Glipizide	71	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	27
Tramadol Hcl	Tramadol Hcl	59	23
Citalopram Hbr	Citalopram Hydrobromide	56	18
Metoprolol Tartrate	Metoprolol Tartrate	54	22
Allopurinol	Allopurinol	53	20
Tamsulosin Hcl	Tamsulosin Hcl	53	24
Pantoprazole Sodium	Pantoprazole Sodium	52	19
Duloxetine Hcl	Duloxetine Hcl	49	19
Triamcinolone Acetonide	Triamcinolone Acetonide	49	35
Metformin Hcl Er	Metformin Hcl	48	21
Pradaxa	Dabigatran Etexilate Mesylate	48	15
Furosemide	Furosemide	46	24
Bupropion Xl	Bupropion Hcl	42	16
Alvesco	Ciclesonide	40	suppressed
Sertraline Hcl	Sertraline Hcl	40	17
Fluoxetine Hcl	Fluoxetine Hcl	39	16
Estradiol	Estradiol	38	24
Acyclovir	Acyclovir	37	18
Wixela Inhub	Fluticasone Propion/Salmeterol	36	14
Humulin N	Insulin Nph Human Isophane	29	suppressed
Mirtazapine	Mirtazapine	29	11
Carvedilol	Carvedilol	26	13
Fluticasone Propionate	Fluticasone Propionate	26	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	25	25
Arexvy	Rsvpref3 Antigen/As01e/Pf	23	23
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Metoprolol Succinate	Metoprolol Succinate	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Ozempic	Semaglutide	22	suppressed
Prednisone	Prednisone	21	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	21	20
Clopidogrel	Clopidogrel Bisulfate	20	11
Jardiance	Empagliflozin	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Trospium Chloride	Trospium Chloride	18	suppressed
Finasteride	Finasteride	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	15
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Topiramate	Topiramate	16	suppressed
Lorazepam	Lorazepam	15	suppressed
Nystatin	Nystatin	15	11
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Ondansetron Odt	Ondansetron	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Retin-A	Tretinoin	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Yuvafem	Estradiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error